143 related articles for article (PubMed ID: 14726530)
1. Real-time analysis of ternary complex on particles: direct evidence for partial agonism at the agonist-receptor-G protein complex assembly step of signal transduction.
Simons PC; Biggs SM; Waller A; Foutz T; Cimino DF; Guo Q; Neubig RR; Tang WJ; Prossnitz ER; Sklar LA
J Biol Chem; 2004 Apr; 279(14):13514-21. PubMed ID: 14726530
[TBL] [Abstract][Full Text] [Related]
2. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.
Seifert R; Wenzel-Seifert K; Gether U; Kobilka BK
J Pharmacol Exp Ther; 2001 Jun; 297(3):1218-26. PubMed ID: 11356949
[TBL] [Abstract][Full Text] [Related]
3. Ligand-receptor-G-protein molecular assemblies on beads for mechanistic studies and screening by flow cytometry.
Simons PC; Shi M; Foutz T; Cimino DF; Lewis J; Buranda T; Lim WK; Neubig RR; McIntire WE; Garrison J; Prossnitz E; Sklar LA
Mol Pharmacol; 2003 Nov; 64(5):1227-38. PubMed ID: 14573773
[TBL] [Abstract][Full Text] [Related]
4. Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor.
Ghanouni P; Gryczynski Z; Steenhuis JJ; Lee TW; Farrens DL; Lakowicz JR; Kobilka BK
J Biol Chem; 2001 Jul; 276(27):24433-6. PubMed ID: 11320077
[TBL] [Abstract][Full Text] [Related]
5. Some mechanistic insights into GPCR activation from detergent-solubilized ternary complexes on beads.
Buranda T; Waller A; Wu Y; Simons PC; Biggs S; Prossnitz ER; Sklar LA
Adv Protein Chem; 2007; 74():95-135. PubMed ID: 17854656
[TBL] [Abstract][Full Text] [Related]
6. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
[TBL] [Abstract][Full Text] [Related]
7. [Molecular mechanisms of regulatory action of adrenergic receptor agonists on functional activity of adenylyl cyclase signaling system of the ciliates Dileptus anser and Tetrahymena pyriformis].
Shpakov AO; Derkach KV; Uspenskaia ZI; Shpakova EA; Kuznetsova LA; Plesneva SA; Pertseva MN
Tsitologiia; 2004; 46(4):317-25. PubMed ID: 15346790
[TBL] [Abstract][Full Text] [Related]
8. Solubilization and display of G protein-coupled receptors on beads for real-time fluorescence and flow cytometric analysis.
Sklar LA; Vilven J; Lynam E; Neldon D; Bennett TA; Prossnitz E
Biotechniques; 2000 May; 28(5):976-80, 982-5. PubMed ID: 10818705
[TBL] [Abstract][Full Text] [Related]
9. Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes.
Gether U; Lin S; Kobilka BK
J Biol Chem; 1995 Nov; 270(47):28268-75. PubMed ID: 7499324
[TBL] [Abstract][Full Text] [Related]
10. Serum and insulin induce a Grb2-dependent shift in agonist affinity of beta-adrenergic receptors.
Shih M; Malbon CC
Cell Signal; 1998 Sep; 10(8):575-82. PubMed ID: 9794256
[TBL] [Abstract][Full Text] [Related]
11. Discovery of regulators of receptor internalization with high-throughput flow cytometry.
Wu Y; Tapia PH; Fisher GW; Simons PC; Strouse JJ; Foutz T; Waggoner AS; Jarvik J; Sklar LA
Mol Pharmacol; 2012 Oct; 82(4):645-57. PubMed ID: 22767611
[TBL] [Abstract][Full Text] [Related]
12. The third extracellular loop of the beta2-adrenergic receptor can modulate receptor/G protein affinity.
Zhao MM; Gaivin RJ; Perez DM
Mol Pharmacol; 1998 Mar; 53(3):524-9. PubMed ID: 9495820
[TBL] [Abstract][Full Text] [Related]
13. Chapter 11. Subsecond analyses of G-protein coupled-receptor ternary complex dynamics by rapid mix flow cytometry.
Buranda T; Wu Y; Sklar LA
Methods Enzymol; 2009; 461():227-47. PubMed ID: 19480922
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
Goetz A; Lanig H; Gmeiner P; Clark T
J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
[TBL] [Abstract][Full Text] [Related]
15. Visualizing differences in ligand regulation of wild-type and constitutively active mutant beta(2)-adrenoceptor-green fluorescent protein fusion proteins.
McLean AJ; Bevan N; Rees S; Milligan G
Mol Pharmacol; 1999 Dec; 56(6):1182-91. PubMed ID: 10570045
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of beta(2)-adrenoceptor coupling to G(s)-, G(i)-, and G(q)-proteins.
Wenzel-Seifert K; Seifert R
Mol Pharmacol; 2000 Nov; 58(5):954-66. PubMed ID: 11040042
[TBL] [Abstract][Full Text] [Related]
17. Effects of guanine, inosine, and xanthine nucleotides on beta(2)-adrenergic receptor/G(s) interactions: evidence for multiple receptor conformations.
Seifert R; Gether U; Wenzel-Seifert K; Kobilka BK
Mol Pharmacol; 1999 Aug; 56(2):348-58. PubMed ID: 10419554
[TBL] [Abstract][Full Text] [Related]
18. Evolving concepts of partial agonism. The beta-adrenergic receptor as a paradigm.
Jasper JR; Insel PA
Biochem Pharmacol; 1992 Jan; 43(2):119-30. PubMed ID: 1346741
[TBL] [Abstract][Full Text] [Related]
19. Ligand regulation of green fluorescent protein-tagged forms of the human beta(1)- and beta(2)-adrenoceptors; comparisons with the unmodified receptors.
McLean AJ; Milligan G
Br J Pharmacol; 2000 Aug; 130(8):1825-32. PubMed ID: 10952671
[TBL] [Abstract][Full Text] [Related]
20. An inactive receptor-G protein complex maintains the dynamic range of agonist-induced signaling.
Jang W; Adams CE; Liu H; Zhang C; Levy FO; Andressen KW; Lambert NA
Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30755-30762. PubMed ID: 33199589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
